Oregon Public Employees Retirement Fund’s Regeneron Pharmaceuticals REGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$7.67M Buy
12,307
+749
+6% +$510K 0.08% 191
2026
Q1
$8.93M Hold
11,558
0.12% 136
2025
Q4
$8.92M Sell
11,558
-109
-0.9% -$74K 0.11% 134
2025
Q3
$6.56M Buy
11,667
+2,736
+31% +$1.55M 0.09% 181
2025
Q2
$4.69M Sell
8,931
-100
-1% -$55.8K 0.08% 182
2025
Q1
$5.73M Buy
9,031
+10
+0.1% +$6.88K 0.11% 143
2024
Q4
$6.43M Buy
9,021
+5
+0.1% +$4.2K 0.12% 128
2024
Q3
$9.48M Sell
9,016
-126
-1% -$140K 0.18% 88
2024
Q2
$9.61M Buy
9,142
+161
+2% +$156K 0.19% 84
2024
Q1
$8.64M Sell
8,981
-2,713
-23% -$2.58M 0.17% 96
2023
Q4
$10.3M Sell
11,694
-7,883
-40% -$6.49M 0.18% 96
2023
Q3
$16.1M Sell
19,577
-5,182
-21% -$4.07M 0.22% 100
2023
Q2
$17.8M Sell
24,759
-5,947
-19% -$4.59M 0.21% 108
2023
Q1
$25.2M Sell
30,706
-477
-2% -$360K 0.31% 73
2022
Q4
$22.5M Buy
31,183
+848
+3% +$626K 0.29% 74
2022
Q3
$20.9M Sell
30,335
-1,500
-5% -$944K 0.3% 63
2022
Q2
$18.8M Buy
31,835
+9,687
+44% +$6.3M 0.29% 62
2022
Q1
$15.5M Sell
22,148
-200
-0.9% -$127K 0.16% 135
2021
Q4
$14.1M Sell
22,348
-122
-0.5% -$75K 0.16% 129
2021
Q3
$13.6M Sell
22,470
-1,051
-4% -$652K 0.16% 131
2021
Q2
$13.1M Sell
23,521
-9,276
-28% -$4.7M 0.15% 142
2021
Q1
$15.5M Buy
32,797
+84
+0.3% +$40.9K 0.18% 115
2020
Q4
$15.8M Sell
32,713
-4,248
-11% -$2.29M 0.21% 97
2020
Q3
$20.7M Sell
36,961
-2,556
-6% -$1.55M 0.31% 61
2020
Q2
$24.6M Sell
39,517
-6,545
-14% -$3.72M 0.36% 47
2020
Q1
$22.5M Buy
46,062
+27,887
+153% +$11.5M 0.39% 53
2019
Q4
$6.82M Sell
18,175
-638
-3% -$215K 0.1% 212
2019
Q3
$5.22M Sell
18,813
-363
-2% -$107K 0.07% 292
2019
Q2
$6M Sell
19,176
-6,851
-26% -$2.28M 0.08% 246
2019
Q1
$10.7M Buy
26,027
+8,434
+48% +$3.47M 0.15% 133
2018
Q4
$6.57M Sell
17,593
-872
-5% -$319K 0.1% 183
2018
Q3
$7.46M Buy
18,465
+124
+0.7% +$47.2K 0.1% 191
2018
Q2
$6.33M Sell
18,341
-504
-3% -$158K 0.09% 222
2018
Q1
$6.49M Buy
18,845
+212
+1% +$73.7K 0.1% 212
2017
Q4
$7M Sell
18,633
-71
-0.4% -$28.8K 0.11% 193
2017
Q3
$8.36M Buy
18,704
+10,794
+136% +$5.14M 0.14% 155
2017
Q2
$3.88M Hold
7,910
0.07% 313
2017
Q1
$3.06M Hold
7,910
0.06% 342
2016
Q4
$2.9M Sell
7,910
-80
-1% -$30.4K 0.06% 335
2016
Q3
$3.21M Sell
7,990
-160
-2% -$64.2K 0.07% 288
2016
Q2
$2.85M Sell
8,150
-4,170
-34% -$1.61M 0.06% 327
2016
Q1
$4.44M Buy
12,320
+443
+4% +$183K 0.1% 199
2015
Q4
$6.45M Buy
11,877
+4,300
+57% +$2.33M 0.15% 134
2015
Q3
$3.52M Hold
7,577
0.09% 230
2015
Q2
$3.87M Buy
7,577
+200
+3% +$97.6K 0.09% 236
2015
Q1
$3.33M Buy
7,377
+100
+1% +$42.4K 0.08% 267
2014
Q4
$2.98M Sell
7,277
-382
-5% -$150K 0.07% 292
2014
Q3
$2.76M Hold
7,659
0.07% 294
2014
Q2
$2.16M Sell
7,659
-6,400
-46% -$1.9M 0.05% 387
2014
Q1
$4.22M Buy
14,059
+200
+1% +$61.6K 0.11% 188
2013
Q4
$3.81M Buy
13,859
+6,600
+91% +$1.9M 0.1% 199
2013
Q3
$2.27M Buy
7,259
+1,533
+27% +$403K 0.09% 226
2013
Q2
$1.29M Buy
+5,726
New +$1.33M 0.06% 403

Other funds holding REGN

Oregon Public Employees Retirement Fund's REGN Position: Q2 2026 in Review

Oregon Public Employees Retirement Fund increased its Regeneron Pharmaceuticals (REGN) stake by 6.5% in Q2 2026, buying an estimated $510K and bringing the position to 12,307 shares worth $7.67M. The position accounts for 0.08% of the portfolio, ranked #191.

Oregon Public Employees Retirement Fund first reported a position in REGN in Q2 2013 and has held it in 53 quarters since. The position peaked at $25.2M in Q1 2023. 1,333 funds tracked by Wall St. Rank hold REGN as of Q2 2026.

  • Oregon Public Employees Retirement Fund held 12,307 shares of Regeneron Pharmaceuticals worth $7.67M as of Q2 2026.
  • Oregon Public Employees Retirement Fund bought 749 Regeneron Pharmaceuticals shares in Q2 2026, an estimated $510K.
  • Regeneron Pharmaceuticals made up 0.08% of Oregon Public Employees Retirement Fund's portfolio in Q2 2026, its #191 holding.
  • Oregon Public Employees Retirement Fund first reported a position in Regeneron Pharmaceuticals in Q2 2013 and has held it in 53 quarters since.
  • Oregon Public Employees Retirement Fund's Regeneron Pharmaceuticals position peaked at $25.2M in Q1 2023.
  • 1,333 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q2 2026.

Based on Oregon Public Employees Retirement Fund's 13F filing for Q2 2026, filed 29 Jul 2026.